Back
abrdn Bloomberg All Commodity Strat K-1 Free ETF Vs. Aligos Therapeutics Industry Stock Comparison
Sell
12
BCI
abrdn Bloomberg All Commodity Strat K-1 Free ETF
Last Price:
$19.57
Seasonality Move:
-2.38%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
12
abrdn Bloomberg All Commodity Strat K-1 Free ETF (BCI)
is a Sell
Is abrdn Bloomberg All Commodity Strat K-1 Free ETF a Buy, Sell or Hold?
-
The current abrdn Bloomberg All Commodity Strat K-1 Free ETF [BCI] share price is $19.55. The Score for BCI is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
BCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCI Stock Price Chart
What is abrdn Bloomberg All Commodity Strat K-1 Free ETF's stock price today?
-
The abrdn Bloomberg All Commodity Strat K-1 Free ETF share price today is $19.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCI is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 36.05 | Sell |
| Chaikin Money Flow: | -61537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.84 - 20.34) | Sell |
| Bollinger Bands (100): | (19.48 - 20.42) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.71 | Buy |
| Relative Strength Index (14 RSI): | 81.52 | Buy |
| Chaikin Money Flow: | 630913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.74 - 36.8) | Buy |
| Bollinger Bands (100): | (6.83 - 25.23) | Buy |
BCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.93 | Sell |
| 20-day SMA: | 20.06 | Sell |
| 50-day SMA: | 20.12 | Sell |
| 200-day SMA: | 20.13 | Sell |
| 8-day EMA: | 19.82 | Sell |
| 20-day EMA: | 19.99 | Sell |
| 50-day EMA: | 20.07 | Sell |
| 200-day EMA: | 20.14 | Sell |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.61 | Buy |
| 20-day SMA: | 32.22 | Buy |
| 50-day SMA: | 20.6 | Buy |
| 200-day SMA: | 16.51 | Buy |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 32.66 | Buy |
| 50-day EMA: | 24.43 | Buy |
| 200-day EMA: | 18.11 | Buy |
abrdn Bloomberg All Commodity Strat K-1 Free ETF Earnings Growth & BCI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
abrdn Bloomberg All Commodity Strat K-1 Free ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 20 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||